Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Halozyme Reaffirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Medicare Drug Price Negotiation Program Final Rule for IPAY 2029
      Biotech

      Halozyme Reaffirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Medicare Drug Price Negotiation Program Final Rule for IPAY 2029

      November 6, 2026
      Cryoport Reports Third Quarter 2026 Financial Results
      Biotech

      Cryoport Reports Third Quarter 2026 Financial Results

      November 6, 2026
      Enliven Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Business Update
      Biotech

      Enliven Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Business Update

      November 6, 2026
      Tyra Biosciences to Participate in Upcoming Investor Conferences
      Biotech

      Tyra Biosciences to Participate in Upcoming Investor Conferences

      November 6, 2026
      HALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
      Biotech

      HALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE

      November 6, 2026
      Castle Biosciences Reports Third Quarter 2026 Results
      Biotech

      Castle Biosciences Reports Third Quarter 2026 Results

      November 6, 2026
      10x Genomics Reports Third Quarter 2026 Financial Results
      Biotech

      10x Genomics Reports Third Quarter 2026 Financial Results

      November 6, 2026
      Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026
      Biotech

      Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026

      November 5, 2026
      Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026
      Biotech

      Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026

      November 5, 2026
      Orchestra BioMed Announces Pricing of Public Offering
      Biotech

      Orchestra BioMed Announces Pricing of Public Offering

      November 5, 2026
      « 1 … 8 9 10 11 12 … 175 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026